Chemours Company (The) (CC): Price and Financial Metrics
Chemours Company (The) (CC)
Today's Latest Price: $21.88 USD
Updated Oct 23 7:00pm
Add CC to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CC Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for CC is 7.82 -- better than 95.43% of US stocks.
- The ratio of debt to operating expenses for Chemours Co is higher than it is for about 86.12% of US stocks.
- CC's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 92.81% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Chemours Co are TWI, NRG, ADNT, CTIB, and WYNN.
- CC's SEC filings can be seen here. And to visit Chemours Co's official web site, go to www.chemours.com.
CC Stock Price Chart Interactive Chart >
CC Price/Volume Stats
| Current price | $21.88 | 52-week high | $23.92 |
| Prev. close | $21.69 | 52-week low | $7.02 |
| Day low | $21.58 | Volume | 556,543 |
| Day high | $22.14 | Avg. volume | 2,383,381 |
| 50-day MA | $21.33 | Dividend yield | 4.57% |
| 200-day MA | $16.02 | Market Cap | 3.59B |
Chemours Company (The) (CC) Company Bio
The Chemours Company is a global leader in titanium technologies, fluoroproducts and chemical solutions. Chemours ingredients are found in plastics and coatings, refrigeration and air conditioning, mining and oil refining operations and general industrial manufacturing. The company was founded in 2015 and is based in Wilmington, Delaware.
CC Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $21.88 | $39.68 | 85% |
We started the process of determining a valid price forecast for Chemours Co with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Chemours Co ranked in the 61th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. In terms of the factors that were most noteworthy in this DCF analysis for CC, they are:
- 43% of the company's capital comes from equity, which is greater than merely 22.01% of stocks in our cash flow based forecasting set.
- Chemours Co's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -0.25. This coverage rate is greater than that of just 24.28% of stocks we're observing for the purpose of forecasting via discounted cash flows.
- As a business, Chemours Co experienced a tax rate of about 73% over the past twelve months; relative to its sector (Basic Materials), this tax rate is higher than 94.77% of stocks generating free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 82% |
| 1% | 84% |
| 2% | 85% |
| 3% | 87% |
| 4% | 89% |
| 5% | 91% |
For other companies in the Basic Materials that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as CC, try SXC, CINR, KRO, TREC, and JELD.
Loading social stream, please wait...